PA
pooja arora
Schrodinger (United States), TCR2 therapeutics, National Institute of Immunology, Pfizer (United States)
Employment
-
Schrodinger (United States) Principal Scientist II2021 - Present
-
TCR2 therapeutics Senior Scientist2020 - 2020
-
Pfizer (United States) Senior Scientist2018 - 2020
-
Albert Einstein College of Medicine Associate (Faculty)2007 - 2018
Education
-
National Institute of Immunology Ph.D in Biochemistry2001 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- Generation of IL-3–Secreting CD4+ T Cells by Microbial Challenge at Skin and Mucosal Barriers Save
- Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity. Save
- Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity Save
- "Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes" Save
- An efficient and high yield method for isolation of mouse dendritic cell subsets Save
- Glycolipid activators of invariant NKT cells as vaccine adjuvants Save
- Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes Save
- A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens Save
- CD1d and natural killer T cells in immunity to mycobacterium Tuberculosis Save
- CD1d and natural killer T cells in immunity to mycobacterium Tuberculosis Save